18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
NCT02175745 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2017-03-20
Summary
To evaluate 18F-FDOPA PET obtained from PET/CT or PET/MRI imaging in patients with newly diagnosed or recurrent gliomas.
Conditions
- Adult Anaplastic Ependymoma
- Adult Anaplastic Oligodendroglioma
- Adult Brain Stem Glioma
- Adult Diffuse Astrocytoma
- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma
- Adult Mixed Glioma
- Adult Oligodendroglioma
- Adult Pilocytic Astrocytoma
- Adult Pineal Gland Astrocytoma
- Adult Subependymal Giant Cell Astrocytoma
- Childhood High-grade Cerebellar Astrocytoma
- Childhood High-grade Cerebral Astrocytoma
- Childhood Low-grade Cerebellar Astrocytoma
- Childhood Low-grade Cerebral Astrocytoma
- Recurrent Adult Brain Tumor
- Recurrent Childhood Anaplastic Astrocytoma
- Recurrent Childhood Anaplastic Oligoastrocytoma
- Recurrent Childhood Anaplastic Oligodendroglioma
- Recurrent Childhood Brain Stem Glioma
- Recurrent Childhood Cerebellar Astrocytoma
- Recurrent Childhood Cerebral Astrocytoma
- Recurrent Childhood Diffuse Astrocytoma
- Recurrent Childhood Fibrillary Astrocytoma
- Recurrent Childhood Gemistocytic Astrocytoma
- Recurrent Childhood Giant Cell Glioblastoma
- Recurrent Childhood Glioblastoma
- Recurrent Childhood Gliomatosis Cerebri
- Recurrent Childhood Gliosarcoma
- Recurrent Childhood Oligoastrocytoma
- Recurrent Childhood Oligodendroglioma
- Recurrent Childhood Pilomyxoid Astrocytoma
- Recurrent Childhood Protoplasmic Astrocytoma
- Recurrent Childhood Subependymal Giant Cell Astrocytoma
- Recurrent Childhood Visual Pathway and Hypothalamic Glioma
- Recurrent Childhood Visual Pathway Glioma
- Untreated Childhood Anaplastic Astrocytoma
- Untreated Childhood Anaplastic Oligoastrocytoma
- Untreated Childhood Anaplastic Oligodendroglioma
- Untreated Childhood Brain Stem Glioma
- Untreated Childhood Cerebellar Astrocytoma
- Untreated Childhood Cerebral Astrocytoma
- Untreated Childhood Diffuse Astrocytoma
- Untreated Childhood Fibrillary Astrocytoma
- Untreated Childhood Gemistocytic Astrocytoma
- Untreated Childhood Giant Cell Glioblastoma
- Untreated Childhood Glioblastoma
- Untreated Childhood Gliomatosis Cerebri
- Untreated Childhood Gliosarcoma
- Untreated Childhood Oligoastrocytoma
- Untreated Childhood Oligodendroglioma
- Untreated Childhood Pilomyxoid Astrocytoma
- Untreated Childhood Protoplasmic Astrocytoma
- Untreated Childhood Subependymal Giant Cell Astrocytoma
- Untreated Childhood Visual Pathway and Hypothalamic Glioma
- Untreated Childhood Visual Pathway Glioma
Interventions
- DRUG
-
18F-fluoro-dihydroxyphenylalanine
Administered intravenously (IV)
- PROCEDURE
-
Positron emission tomography (PET)
Component of an 18F-FDOPA PET/CT or PET/MRI scan
- PROCEDURE
-
Computed tomography (CT)
Component of an 18F-FDOPA PET/CT
- PROCEDURE
-
Magnetic resonance imaging
Component of an 18F-FDOPA PET/MRI
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Erik Mittra
lead OTHER
Principal Investigators
-
Erik Mittra, MD, PhD · Stanford University Hospitals and Clinics
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
NCT00214175 ·Status: COMPLETED
-
Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI
NCT04097535 ·Status: COMPLETED
-
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
NCT04044937 ·Status: COMPLETED ·Phase: PHASE2
-
Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas
NCT04766632 ·Status: COMPLETED ·Phase: NA
-
Image-Guided Stereotactic Biopsy of High Grade Gliomas
NCT00979810 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
NCT01880008 ·Status: COMPLETED
-
PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
NCT01800032 ·Status: COMPLETED
-
PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor
NCT02071017 ·Status: UNKNOWN
-
MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer
NCT00984074 ·Status: COMPLETED
-
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
NCT01222728 ·Status: COMPLETED
-
FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
NCT01089244 ·Status: UNKNOWN
-
Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.
NCT05672082 ·Status: WITHDRAWN ·Phase: NA
-
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
NCT00274755 ·Status: COMPLETED ·Phase: PHASE2
-
18F-Fluciclovine PET-MRI in High-grade Glioma
NCT05553041 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
NCT06474533 ·Status: RECRUITING
-
Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
NCT06455189 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas
NCT06499831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NCT04033497 ·Status: RECRUITING ·Phase: NA
-
Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
NCT01252459 ·Status: UNKNOWN ·Phase: PHASE2
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
NCT00659126 ·Status: TERMINATED ·Phase: PHASE2
-
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005083 ·Status: WITHDRAWN ·Phase: PHASE2
-
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
NCT03952598 ·Status: SUSPENDED ·Phase: PHASE2
-
FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
NCT03370926 ·Status: UNKNOWN
-
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
NCT00060008 ·Status: TERMINATED ·Phase: NA